Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2009-8-26
pubmed:abstractText
Placental growth factor (PlGF), a homolog of vascular endothelial growth factor, is reported to stimulate angiogenesis and arteriogenesis in pathological conditions. It was recently demonstrated that PlGF is rapidly produced in myocardial tissue during acute myocardial infarction (MI). However, the effects of exogenous PlGF administration on the healing process after MI are not fully understood. The purpose of the present study was to examine whether PlGF treatment has therapeutic potential in MI.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Actins, http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inducing Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD31, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Ly, http://linkedlifedata.com/resource/pubmed/chemical/FLT1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Green Fluorescent Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ly6a protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Pregnancy Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor..., http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor..., http://linkedlifedata.com/resource/pubmed/chemical/placenta growth factor
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1347-4820
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
73
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1674-82
pubmed:dateRevised
2009-11-25
pubmed:meshHeading
pubmed-meshheading:19602778-Actins, pubmed-meshheading:19602778-Angiogenesis Inducing Agents, pubmed-meshheading:19602778-Animals, pubmed-meshheading:19602778-Antigens, CD31, pubmed-meshheading:19602778-Antigens, Ly, pubmed-meshheading:19602778-Cell Differentiation, pubmed-meshheading:19602778-Cell Movement, pubmed-meshheading:19602778-Coronary Vessels, pubmed-meshheading:19602778-Disease Models, Animal, pubmed-meshheading:19602778-Endothelial Cells, pubmed-meshheading:19602778-Green Fluorescent Proteins, pubmed-meshheading:19602778-Humans, pubmed-meshheading:19602778-Infusion Pumps, Implantable, pubmed-meshheading:19602778-Membrane Proteins, pubmed-meshheading:19602778-Mice, pubmed-meshheading:19602778-Mice, Inbred C57BL, pubmed-meshheading:19602778-Mice, Transgenic, pubmed-meshheading:19602778-Myocardial Infarction, pubmed-meshheading:19602778-Neovascularization, Physiologic, pubmed-meshheading:19602778-Pregnancy Proteins, pubmed-meshheading:19602778-Recombinant Proteins, pubmed-meshheading:19602778-Stem Cells, pubmed-meshheading:19602778-Time Factors, pubmed-meshheading:19602778-Vascular Endothelial Growth Factor Receptor-1, pubmed-meshheading:19602778-Vascular Endothelial Growth Factor Receptor-2, pubmed-meshheading:19602778-Ventricular Function, Left, pubmed-meshheading:19602778-Ventricular Remodeling
pubmed:year
2009
pubmed:articleTitle
Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction.
pubmed:affiliation
First Department of Internal Medicine, Nara Medical University, Kashihara, Japan.
pubmed:publicationType
Journal Article